Glenmark plans US clinical trials on drug

Glenmark plans US clinical trials on drug
Comment E-mail Print Share
First Published: Thu, Sep 11 2008. 12 29 PM IST
Updated: Thu, Sep 11 2008. 12 29 PM IST
Mumbai: Glenmark Pharmaceuticals on Thursday said it has filed for approval to start initial stage clinical trials of experimental biological drug £500 with the US Food and Drug Administration.
The drug is a monoclonal antibody, which Glenmark hopes to initially develop as a treatment for multiple sclerosis.
Glenmark expects to complete the trials in the current financial year, it said in a statement.
Biological drugs are complex, larger molecules made from living organisms and are generally considered more difficult to develop than smaller chemical molecules.
Comment E-mail Print Share
First Published: Thu, Sep 11 2008. 12 29 PM IST
More Topics: Glenmark | Pharma | Medicines | US | Corporate News |